GlassScriptPhysician profile
Eric R Gaughan
NPI 1568894517
$3,076.44
in general payments reported to CMS, 2019-2025
16 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $88.04 · 2021: $356 · 2022: $1,191 · 2023: $315 · 2024: $182 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,288.64 | 2022-2025 | |
| Smith+Nephew, INC. | $350.67 | 2019-2025 | Stravix Pl, Collagenase Santyl |
| Horizon Therapeutics Plc | $270.43 | 2019-2023 | Krystexxa |
| Bioventus LLC | $249.83 | 2020-2022 | |
| Organogenesis INC. | $193.48 | 2019-2025 | Puraply Wound Matrix, Via Matrix, Cygnus Dual |
| Misonix INC | $148.95 | 2019-2020 | |
| Paragon 28, INC. | $143.89 | 2019-2023 | Mtp, Paratrooper |
| Amgen INC. | $86.80 | 2024-2025 | Krystexxa |
| Anika Therapeutics, INC. | $74.31 | 2021 | |
| Linvatec Corporation | $73.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $52.59 | 2019 | |
| Biopro, INC. | $44.29 | 2019 | |
| Convatec INC. | $31.99 | 2023 | |
| Abbott Laboratories | $25.62 | 2023 | Prodigy |
| Kerecis Limited | $22.30 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $18.68 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.